ARCHIVES

Cancer PAC Advocated At AACR Meeting

This article is from The Cancer Letter archive.

Vol. 12 No. 21 | May 23, 1986

Download PDF Visit The Full Archive

Related Articles

NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985

June 8, 1979

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

Wittes, Fraumeni Appointed As Division Directors

February 9, 1996

Four RFAs Released For RM Program

November 6, 1981

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001